Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01662414 : Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
PhasePhase 4
AgesMin: 30 Years Max: 80 Years
Eligibility
Inclusion Criteria:

1. Subjects with Idiopathic Parkinson's Disease

2. Subjects who are willing and able to participate in the trial and has provided
written, informed consent.

Exclusion Criteria:

1. Subjects who are allergic to Whey protein (HMS 90®).

2. Subjects who are treated with chemotherapy .

3. Subjects with any history of neurodegenerative diseases, e.g., Alzheimer's disease.

4. Subjects with history of diabetes. 4.5. Subjects with abnormal liver function test
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01662414      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740